Activity Preview


PIP: Clinical Module for Screening Adult Psychiatric Patients for Substance Use Disorders

Activity Type:

  • Performance in Practice (PIP)

Release Date: 9/1/2018

Expiration Date: 9/1/2021

  • AMA PRA Category 1: 20
  • Participation: 20

Access Activity


Completion of Stages A, B, and C in sequence is designated by American Psychiatric Association for 20 AMA PRA Category 1 Credits™.  This activity is approved by American Board of Psychiatry and Neurology (ABPN) for MOC Part 4 Clinical Module.

The American Psychiatric Association’s (APA) Improvement in Medical Practice/Performance in Practice (PIP) clinical modules are designed to meet the requirements of the American Board of Medical Specialties (ABMS) and American Board of Psychiatry and Neurology (ABPN) Part 4 of Maintenance of Certification (MOC). PIP clinical modules are intended to assist in physicians’ evaluation of the quality of care provided in their practice, compared with national benchmarks, and to facilitate practice improvements through the incorporation of best evidence or consensus recommendations to improve patient care.

There are three stages involved in each PIP unit:
• Stage A, the baseline retrospective chart review of at least 5 patients in a specified category, which is then compared with “published best practices, practice guidelines, or peer-based standards”;
• Stage B, the design and implementation of a practice improvement plan; and 
• Stage C, subsequent remeasurement via a second chart review of 5 patients within the same category within 24 months after the initial chart review.


  • General Member - Free
  • Resident-Fellow Member - Free
  • Medical Student Member - Free
  • Non-Member - $399.00

Educational Objectives

By completing the clinical module, physicians will:

  • assess whether their current screening is consistent with evidence-based recommendations;
  • identify areas of improvement and develop an improvement plan; and
  • improve screening for substance use disorders in clinical practice.

Target Audience

Psychiatrists participating in MOC and other psychiatrists in clinical practice; psychiatric residents and fellows; physicians who wish to improve their knowledge of clinical psychiatry and patient care; all clinicians interested in substance screening.

Estimated Time to Complete

Duration: 20 hours
Begin Date: September 1, 2018
End Date: September 1, 2021

How to Earn Credit

The PIP Modules follow a three-stage Performance Improvement CME structure that takes place within a 24-month period.

Use the "View All Events" tab to navigate through the three stages of the course.

  • In Stage A - Chart Review, the physician compares his or her current practice (through a review of chart documentation) to guidelines and measures provided for the topic area. No patient/chart data is submitted. (5 credits)
  • In Stage B – Improvement, based upon the results of chart review, the physician then selects an area where improvement is needed and documents his or her strategy for improvement. This improvement plan is for the personal use of the physician and is not submitted to the APA. Educational resources are suggested that can assist with the improvement plan, however, any educational activities relevant to the improvement plan can be used. During Stage B, the physician implements the educational plan for a recommended period of at least 30 days or as long as the doctor deems necessary. (5 credits)
  • In Stage C – Second Chart Review, the physician reassesses his or her performance with review of 5 patient charts and determines the results of his or her performance improvement effort. These can be the same 5 patients, or a new group of patients seen since beginning the PIP activities. Again, the physician retains all patient/chart data. (10 credits)

The complete module, three stages in sequence within 24 months, earns the participant a total of 20 AMA PRA Category 1 credits ™.


The American Psychiatric Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.  The American Psychiatric Association designates this PI CME for a maximum of 20 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Board of Psychiatry and Neurology has reviewed the PIP: Clinical Module for Screening Adult Psychiatric Patients for Substance Use Disorders and has approved this program as a Performance in Practice Clinical Module (MOC Part 4) which is mandated by the ABMS as a necessary component of Maintenance of Certification.

APA reports MOC completion data on behalf of our members directly to ABPN, however, diplomates are still required by ABPN to log on to their ABPN Physician Folios at least once per calendar year to attest to completion of their MOC activities.

Faculty and Planner Disclosures

All planners and authors report no financial relationships with commercial interests.

Program Planners

  • Tristan Gorrindo, M.D. Director Division of Education, and Deputy Medical Director, American Psychiatric Association
  • Deborah J. Hales, M.D., Former Director, American Psychiatric Association Division of Education, Arlington, VA
  • Mark Hyman Rapaport, M.D., Chairman, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, and Chief of Psychiatric Services, Emory Healthcare System, Atlanta, GA


  • Farifteh F. Duffy, Ph.D., Quality Care Research Director, American Psychiatric Foundation Research Network and American Psychiatric Association, Arlington, VA
  • Joyce C. West, Ph.D., M.P.P., Health Policy Research Director, American Psychiatric Foundation Research Network and American Psychiatric Association, Arlington, VA
  • Laura J. Fochtmann, M.D., M.B.I., Professor, Department of Psychiatry and Behavioral Science and Department of Pharmacological Sciences, State University of New York at Stony Brook, and Practice Guidelines Medical Editor, American Psychiatric Association
  • Mark L. Willenbring, M.D., Alltyr, St. Paul, MN
  • Beatrice Eld, B.S., Division of Education, American Psychiatric Association, Arlington, VA 
  • William E. Narrow, M.D., M.P.H., St. Elizabeths Hospital, Washington, DC

2018 Review: John A. Renner, M.D., Associate Chief of Psychiatry Boston VA Healthcare System and Professor of Psychiatry, Boston University School of Medicine. Dr. Renner reports the following relationship: Stockholder: Johnson and Johnson

Hardware/Software Requirements

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration:

  • Flash Player: Adobe Flash Player 10.3+ 
  • Browser: Firefox (latest version), Internet Explorer 8.0+, Safari 7.0+, Microsoft Edge (latest version) or Google Chrome (latest version)
  • Operating System: Windows XP+ or Mac OS X 10.4+ 
  • Internet Connection: 1 Mbps or higher

Minimum Requirements:

  • Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Macromedia Flash Player 10.3 or higher; Sound Card at least 16-bit; audio playback with speakers for programs with video content
  • Macintosh:Mac OS X 10.4+ or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit; audio playback with speakers for programs with video content

For assistance: Contact for questions about this course | Contact for technical assistance


Access Activity